Landscapes / Targets

PDE4

8 drugs act on PDE4, in 27 active trials · Any stage · updated 19 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs8

DrugHow it worksCompanyStageNext dateDetails
PDE3/PDE4 inhibitor (inhaled)
Merck & Co. +1 · Public MRK
Approved 1 Mar 2027Phase 2 trial completes
PDE4B-preferring PDE4 inhibitor
Approved 15 Apr 2027Phase 3 trial completes
—
Approved Aug 2027Phase 4 trial completes
Phosphodiesterase 4 inhibitor
Amgen · Public AMGN
Approved 21 Mar 2028Phase 3 trial completes
—
Phase 3 30 Dec 2026Phase 2 trial completes
—
Phase 3 Feb 2027Phase 3 trial completes
—
Phase 3 30 Sep 2027Phase 3 trial completes
—
Phase 2 Oct 2027Phase 2 trial completes

About this list

Checked
8 of 8 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow PDE4

Following is part of Solo: you see every change to PDE4 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in